Elgethun Capital Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Elgethun Capital Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,000	Closed	-$29K	–	98
2018 Q1	$29K	Hold	1,000	–	–	0.02%	94
2017 Q4	$28K	Hold	1,000	–	–	0.02%	90
2017 Q3	$37K	Hold	1,000	–	–	0.03%	86
2017 Q2	$22K	Hold	1,000	–	–	0.02%	83
2017 Q1	$6K	Hold	1,000	–	–	﹤0.01%	79
2016 Q4	$5K	Buy	+1,000	New	+$6.67K	﹤0.01%	247

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Elgethun Capital Management's AVEO Position: Q2 2018 in Review

Elgethun Capital Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2018, closing a stake of 1,000 shares — an estimated $29K sold.

Elgethun Capital Management first reported a position in AVEO in Q4 2016 and held it in 6 quarters. The position peaked at $37K in Q3 2017. 94 funds tracked by Wall St. Rank hold AVEO as of Q2 2018.

Elgethun Capital Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
Elgethun Capital Management sold 1,000 AVEO Pharmaceuticals, Inc. shares in Q2 2018, an estimated $29K.
Elgethun Capital Management first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2016 and held it in 6 quarters.
Elgethun Capital Management's AVEO Pharmaceuticals, Inc. position peaked at $37K in Q3 2017.
94 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2018.

Based on Elgethun Capital Management's 13F filing for Q2 2018, filed 10 Aug 2018.